He says:
Rough notes on the phone. My summary-in the end OSP stands out-to maintain profitability in the long term:
-Expansion of business in the United States, signed two distribution agreements in Q: strong verification of technology and global market access, and now a strong foundation for growth
-The impact of healthcare on the global COVID, but Osprey's procedures in the United States have grown
-Due to the resurrection of COVID, the growth rate in July was lower than expected in July, but the growth rates in August and September were 40% and 50% in September, respectively
-The sales team reduced the cost by 50%, and the overall cost was greatly reduced.
-GE will bring in additional fourth-quarter revenue, and by 2021, GE will generate substantial "double-digit growth" in sales
-GE bundles Dyevert with GE's advanced dye technology (accounting for 25-30% of the entire dye market)-and how to use mature marketing tools as part of AKI's product portfolio to position, brand and more than 100 sales teams worldwide
-The U.S. price is about US$350-It is agreed that the price in the EU market will not be lower than the U.S. price-In essence, OSP receives a fixed income per unit stream from GE, which will double year-on-year
A total of about 250 units in July, 40% increase in August compared to July, and 50% in September
-The October quarter is expected to show the growth of the third quarter as scheduled!
OSP Price at posting:
2.0¢ Sentiment: Buy Disclosure: Held